ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 15628 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 15628; 2) Community: the network communities that were significantly associated with the response to NSC 15628; 3) Molecule: the relationships between components within communities and NSC 15628; 4) MDR: the compounds that were significantly associated with the NSC 15628.

NSC Compound Enrichment Correlation
NSC 726718 3-(Benzothiazol-6-ylamino)-7-chloro-8-methyl-1,1,-dioxo-4H-1 ,5,2-benzodithiazepin-4-ylideneacetic acid 0.00396536695012846 0.28336177
NSC 730460 16-[4-{(3-Imidazol-1-yl)propoxy}-3-methoxybenzylidene]-3b-py rrolidino-5-androsten-17b-YL acetate 0.00396536695012846 0.47375583
NSC 744178 Null 0.00396536695012846 0.40161297
NSC 747448 3,19-(2,6-Dimethyoxy)benzylidineandrographolide 0.00396536695012846 0.410022
NSC 750039 Null 0.00396536695012846 0.26487586
NSC 757098 Melphalan (USAN) 0.00396536695012846 0.31246127
NSC 86371 Quinolinium, 2-[2-(8-hydroxy-5-methyl-7-quinolyl)vinyl]-1,6-dimethyl- iodide 0.00396536695012846 0.34430096
NSC 90137 Benzene, 1-[(2,4-dinitrophenyl)thio]-4-methyl-2-nitro- 0.00396536695012846 0.45366875
NSC 677666 Null 0.00456325077253396 0.30695964
NSC 696660 (6R,6S)-2,4-Diamino-6-(3,4-dimethoxybenzyl)-5,6,7,8-tetrahydroquinazoline 0.00456325077253396 -0.13584939
Total:140  Current:25    [First] [Prev] [Next] [Last]